HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1901	11225 Kirkitadze MD, Bitan G, Teplow DB Paradigm shifts in Alzheimer's disease and other neuro degenerative disorders: The emerging role of oligomeric assemblies JOURNAL OF NEUROSCIENCE RESEARCH. 2002 SEP 1; 69 (5): 567-577	27	217	32	154
1902	11274 Thompson AJ, Barrow CJ Protein conformational misfolding and amyloid formation: Characteristics of a new class of disorders that include Alzheimer's and prion diseases CURRENT MEDICINAL CHEMISTRY. 2002 OCT; 9 (19): 1751-1762	7	23	32	164
1903	11299 Dong ZZ, Ferger B, Feldon J, Bueler H Overexpression of Parkinson's disease-associated alpha-synuclein(A53T) by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP JOURNAL OF NEUROBIOLOGY. 2002 OCT; 53 (1): 1-10	17	21	32	47
1904	11471 Li L, von Bergen M, Mandelkow EM, Mandelkow E Structure, stability, and aggregation of paired helical filaments from tau protein and FTDP-17 mutants probed by tryptophan scanning mutagenesis JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 NOV 1; 277 (44): 41390-41400	25	37	32	54
1905	11775 Schluter OM, Fornai F, Alessandri MG, Takamori S, Geppert M, et al. Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetra- hydropyridine-induced parkinsonism in mice NEUROSCIENCE. 2003; 118 (4): 985-1002	43	53	32	95
1906	11889 Cho JH, Johnson GVW Glycogen synthase kinase 3 beta phosphorylates tau at both primed and unprimed sites - Differential impact on microtubule binding JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 JAN 3; 278 (1): 187-193	43	82	32	62
1907	11991 Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2003 FEB 18; 100 (4): 2047-2052	40	100	32	62
1908	12102 Yang YF, Nishimura I, Imai Y, Takahashi R, Lu BW Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila NEURON. 2003 MAR 27; 37 (6): 911-924	112	181	32	50
1909	12144 Watson DJ, Longhi L, Lee EB, Fulp CT, Fujimoto S, et al. Genetically modified NT2N human neuronal cells mediate long-term gene expression as CNS grafts in vivo and improve functional cognitive outcome following experimental traumatic brain injury JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2003 APR; 62 (4): 368-380	46	46	32	61
1910	12395 Gervasi C, Thyagarajan A, Szaro BG Increased expression of multiple neurofilament mRNAs during regeneration of vertebrate central nervous system axons JOURNAL OF COMPARATIVE NEUROLOGY. 2003 JUN 23; 461 (2): 262-275	4	11	32	81
#	Date / Author / Journal	LCS	GCS	LCR	CR
1911	12414 Beach TG, Sue L, Scott S, Layne K, Newell A, et al. Hippocampal sclerosis dementia with tauopathy BRAIN PATHOLOGY. 2003 JUL; 13 (3): 263-278	18	30	32	54
1912	12461 Frank RA, Galasko D, Hampel H, Hardy J, de Leon MJ, et al. Biological markers for therapeutic trials in Alzheimer's disease - Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease NEUROBIOLOGY OF AGING. 2003 JUL-AUG; 24 (4): 521-536	120	119	32	165
1913	12466 Dev KK, van der Putten H, Sommer B, Rovelli G Part I: Parkin-associated proteins and Parkinson's disease NEUROPHARMACOLOGY. 2003 JUL; 45 (1): 1-13	15	35	32	102
1914	12614 Bussiere T, Giannakopoulos P, Bouras C, Perl DP, Morrison JH, et al. Progressive degeneration of nonphosphorylated neurofilament protein- enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: Stereologic analysis of prefrontal cortex area 9 JOURNAL OF COMPARATIVE NEUROLOGY. 2003 AUG 25; 463 (3): 281-302	14	36	32	102
1915	12632 Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, et al. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice AMERICAN JOURNAL OF PATHOLOGY. 2003 SEP; 163 (3): 1057-1067	20	40	32	50
1916	12682 Lee SS, Kim YM, Junn E, Lee G, Park KH, et al. Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies NEUROBIOLOGY OF AGING. 2003 SEP; 24 (5): 687-696	18	33	32	82
1917	12792 Andringa G, Du F, Chase TN, Bennett MC Mapping of rat brain using the synuclein-1 monoclonal antibody reveals somatodendritic expression of alpha-synuclein in populations of neurons homologous to those vulnerable to Lewy body formation in human synucleopathies JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2003 OCT; 62 (10): 1060-1075	10	11	32	62
1918	13101 Petrucelli L, Dawson TM Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system ANNALS OF MEDICINE. 2004; 36 (4): 315-320	18	53	32	56
1919	13336 Bartzokis G Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease NEUROBIOLOGY OF AGING. 2004 JAN; 25 (1): 5-18	17	187	32	272
1920	13914 Pickering-Brown SM, Baker M, Nonaka T, Ikeda K, Sharma S, et al. Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene BRAIN. 2004 JUN; 127: 1415-1426	25	25	32	37
#	Date / Author / Journal	LCS	GCS	LCR	CR
1921	13923 Imai Y, Takahashi R How do Parkin mutations result in neurodegeneration? CURRENT OPINION IN NEUROBIOLOGY. 2004 JUN; 14 (3): 384-389	13	25	32	51
1922	14114 Hasegawa T, Matsuzaki M, Takeda A, Kikuchi A, Akita H, et al. Accelerated alpha-synuclein aggregation after differentiation of SH- SY5Y neuroblastoma cells BRAIN RESEARCH. 2004 JUL 2; 1013 (1): 51-59	23	30	32	53
1923	14510 Wirths O, Multhaup G, Bayer TA A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide - the first step of a fatal cascade JOURNAL OF NEUROCHEMISTRY. 2004 NOV; 91 (3): 513-520	33	112	32	75
1924	14584 Lee JC, Langen R, Hummel PA, Gray HB, Winkler JR alpha-synuclein structures from fluorescence energy-transfer kinetics: Implications for the role of the protein in Parkinson's disease PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004 NOV 23; 101 (47): 16466-16471	28	52	32	65
1925	14621 Hashimoto M, Rockenstein E, Mante M, Crews L, Bar-On P, et al. An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model GENE THERAPY. 2004 DEC; 11 (23): 1713-1723	30	35	32	49
1926	14692 Cherny D, Hoyer W, Subramaniam V, Jovin TM Double-stranded DNA stimulates the fibrillation of alpha-synuclein in vitro and is associated with the mature fibrils: An electron microscopy study JOURNAL OF MOLECULAR BIOLOGY. 2004 DEC 3; 344 (4): 929-938	7	15	32	58
1927	14753 Schmidt B, Braun HA, Narlawar R Drug development and PET-diagnostics for Alzheimer's disease CURRENT MEDICINAL CHEMISTRY. 2005; 12 (14): 1677-1695	2	17	32	248
1928	14840 Diaz-Corrales FJ, Asanuma M, Miyazaki I, Miyoshi K, Ogawa N Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: Relevance to formation of inclusion bodies and neurodegeneration NEUROSCIENCE. 2005; 133 (1): 117-135	7	21	32	84
1929	14848 Woodhouse A, West AK, Chuckowree JA, Vickers JC, Dickson TC Does beta-amyloid plaque formation cause structural injury to neuronal processes? NEUROTOXICITY RESEARCH. 2005; 7 (1-2): 5-15	3	7	32	104
1930	15000 Eliezer D, Barre P, Kobaslija M, Chan D, Li XH, et al. Residual structure in the repeat domain of tau: Echoes of microtubule binding and paired helical filament formation BIOCHEMISTRY. 2005 JAN 25; 44 (3): 1026-1036	14	31	32	82
#	Date / Author / Journal	LCS	GCS	LCR	CR
1931	15042 Yamada M, Mizuno Y, Mochizuki H Parkin gene therapy for alpha-synucleinopathy: A rat model of Parkinson's disease HUMAN GENE THERAPY. 2005 FEB; 16 (2): 262-270	33	48	32	51
1932	15067 Specht CG, Tigaret CM, Rast GF, Thalhammer A, Rudhard Y, et al. Subcellular localisation of recombinant alpha- and gamma-synuclein MOLECULAR AND CELLULAR NEUROSCIENCE. 2005 FEB; 28 (2): 326-334	16	19	32	49
1933	15462 Yang WC, Ang LC, Strong MJ Tau protein aggregation in the frontal and entorhinal cortices as a function of aging DEVELOPMENTAL BRAIN RESEARCH. 2005 MAY 12; 156 (2): 127-138	8	13	32	62
1934	15529 Bertram L, Tanzi RE The genetic epidemidogy of neurodegenerative disease JOURNAL OF CLINICAL INVESTIGATION. 2005 JUN; 115 (6): 1449-1457	19	91	32	99
1935	15602 Shin YG, Klucken J, Patterson C, Hyman BT, McLean PJ The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 JUN 24; 280 (25): 23727-23734	45	80	32	63
1936	15784 Fillon G, Kahle PJ Alpha-synuclein transgenic mice: Relevance to multiple system atrophy MOVEMENT DISORDERS. 2005 AUG; 20: S64-S66	6	6	32	39
1937	15891 Luna-Munoz J, Garcia-Sierra F, Falcon V, Menendez I, Chavez-Macias L, et al. Regional conformational change involving phosphorylation of tau protein at the Thr(231), precedes the structural change detected by Alz-50 antibody in Alzheimer's disease JOURNAL OF ALZHEIMERS DISEASE. 2005 SEP; 8 (1): 29-41	13	17	32	63
1938	15933 Flower TR, Chesnokova LS, Froelich CA, Dixon C, Witt SN Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease JOURNAL OF MOLECULAR BIOLOGY. 2005 SEP 2; 351 (5): 1081-1100	32	62	32	72
1939	15938 Sakaue F, Saito T, Sato Y, Asada A, Ishiguro K, et al. Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39 JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 SEP 9; 280 (36): 31522-31529	9	19	32	47
1940	16083 Rodriguez-Martin T, Garcia-Blanco MA, Mansfield SG, Grover AC, Hutton M, et al. Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: Implications for tauopathies PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2005 OCT 25; 102 (43): 15659-15664	11	19	32	49
#	Date / Author / Journal	LCS	GCS	LCR	CR
1941	16168 Rampello L, Butta V, Raffaele R, Vecchio I, Battaglia G, et al. Progressive supranuclear palsy: A systematic review NEUROBIOLOGY OF DISEASE. 2005 NOV; 20 (2): 179-186	8	15	32	108
1942	16198 Springer W, Hoppe T, Schmidt E, Baumeister R A Caenorhabditis elegans Parkin mutant with altered solubility couples alpha-synuclein aggregation to proteotoxic stress HUMAN MOLECULAR GENETICS. 2005 NOV 15; 14 (22): 3407-3423	16	32	32	64
1943	16749 Pitkanen A, McIntosh TK Animal. models of post-traumatic epilepsy JOURNAL OF NEUROTRAUMA. 2006 FEB; 23 (2): 241-261	6	29	32	156
1944	17382 Nunomura A, Castellani RJ, Zhu XW, Moreira PI, Perry G, et al. Involvement of oxidative stress in Alzheimer disease JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2006 JUL; 65 (7): 631-641	28	111	32	148
1945	17736 Klegeris A, Giasson BI, Zhang H, Maguire J, Pelech S, et al. Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells FASEB JOURNAL. 2006 OCT; 20 (12): 2000-2008	20	33	32	56
1946	17867 Gros-Louis F, Gaspar C, Rouleau GA Genetics of familial and sporadic amyotrophic lateral sclerosis BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2006 NOV-DEC; 1762 (11-12): 956-972	38	80	32	186
1947	17880 Mackenzie IRA, Baker M, Pickering-Brown S, Hsiung GYR, Lindholm C, et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene BRAIN. 2006 NOV; 129: 3081-3090	93	97	32	57
1948	17902 Codita A, Winblad B, Mohammed AH Of mice and men: more neurobiology in dementia CURRENT OPINION IN PSYCHIATRY. 2006 NOV; 19 (6): 555-563	3	10	32	130
1949	18161 Beghi E, Mennini T, Bendotti C, Bigini P, Logroscino G, et al. The heterogeneity of amyotrophic lateral sclerosis: A possible explanation of treatment failure CURRENT MEDICINAL CHEMISTRY. 2007; 14 (30): 3185-3200	5	15	32	321
1950	18207 Luo GR, Chen S, Le WD Are heat shock proteins therapeutic target for Parkinson's disease? INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. 2007; 3 (1): 20-26	3	8	32	69
#	Date / Author / Journal	LCS	GCS	LCR	CR
1951	18246 Olanow CW The pathogenesis of cell death in Parkinson's disease - 2007 MOVEMENT DISORDERS. 2007; 22: S335-S342	17	51	32	96
1952	18347 Krishnan KRR Concept of disease in geriatric psychiatry AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2007 JAN; 15 (1): 1-11	0	3	32	100
1953	18583 Sundar PD, Yu CE, Sieh W, Steinbart E, Garruto RM, et al. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia HUMAN MOLECULAR GENETICS. 2007 FEB 1; 16 (3): 295-306	16	18	32	73
1954	18735 Fischer D, Mukrasch MD, von Bergen M, Klos-Witkowska A, Biernat J, et al. Structural and microtubule binding properties of tau mutants of frontotemporal dementias BIOCHEMISTRY. 2007 MAR 13; 46 (10): 2574-2582	6	9	32	52
1955	18799 Whitwell JL, Jack CR, Parisi JE, Knopman DS, Boeve BF, et al. Rates of cerebral atrophy differ in different degenerative pathologies BRAIN. 2007 APR; 130: 1148-1158	14	32	32	85
1956	18913 Avraham E, Rott R, Liani E, Szargel R, Engelender S Phosphorylation of parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 APR 27; 282 (17): 12842-12850	16	23	32	51
1957	19024 Steinhilb ML, Dias-Santagata D, Mulkearns EE, Shulman JM, Biernat J, et al. S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila JOURNAL OF NEUROSCIENCE RESEARCH. 2007 MAY 1; 85 (6): 1271-1278	23	25	32	46
1958	19166 Thyagarajan A, Strong MJ, Szaro BG Post-transcriptional control of neurofilaments in development and disease EXPERIMENTAL CELL RESEARCH. 2007 JUN 10; 313 (10): 2088-2097	5	13	32	98
1959	19518 Walton JR An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration JOURNAL OF INORGANIC BIOCHEMISTRY. 2007 SEP; 101 (9): 1275-1284	8	21	32	93
1960	19595 Li Q, Min JK, Ahn YH, Namm JH, Kim EM, et al. Styryl-based compounds as potential in vivo imaging agents for beta- amyloid plaques CHEMBIOCHEM. 2007 SEP 24; 8 (14): 1679-1687	2	14	32	54
#	Date / Author / Journal	LCS	GCS	LCR	CR
1961	19664 Lin YT, Cheng JT, Liang LC, Ko CY, Lo YK, et al. The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3 beta JOURNAL OF NEUROCHEMISTRY. 2007 OCT; 103 (2): 802-813	8	13	32	50
1962	19685 Uversky VN Nanoimaging in protein-misfolding and -conformational diseases NANOMEDICINE. 2007 OCT; 2 (5): 615-643	2	8	32	202
1963	19744 Cummings JL, Rachelle D, Clark C Disease-modifying therapies for Alzheimer disease NEUROLOGY. 2007 OCT 16; 69 (16): 1622-1634	23	62	32	156
1964	19756 Ingelsson M, Ramasamy K, Russ C, Freeman SH, Orne J, et al. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains ACTA NEUROPATHOLOGICA. 2007 NOV; 114 (5): 471-479	6	8	32	37
1965	19772 Selenica ML, Jensen HS, Larsen AK, Pedersen ML, Helboe L, et al. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation BRITISH JOURNAL OF PHARMACOLOGY. 2007 NOV; 152 (6): 959-979	12	24	32	72
1966	19910 Staal JA, Dickson TC, Chung RS, Vickers JC Cyclosporin-A treatment attenuates delayed cytoskeletal alterations and secondary axotomy following mild axonal stretch injury DEVELOPMENTAL NEUROBIOLOGY. 2007 DEC; 67 (14): 1831-1842	2	5	32	65
1967	20775 Nathalie P, Jean-Noel O Processing of amyloid precursor protein and amyloid peptide neurotoxicity CURRENT ALZHEIMER RESEARCH. 2008 APR; 5 (2): 92-99	3	11	32	146
1968	20888 Kostka M, Hogen T, Danzer KM, Levin J, Habeck M, et al. Single particle characterization of iron-induced pore-forming alpha- synuclein oligomers JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 APR 18; 283 (16): 10992-11003	20	28	32	64
1969	20986 Schaeffer EL, Gattaz WF Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A(2) enzyme PSYCHOPHARMACOLOGY. 2008 MAY; 198 (1): 1-27	2	18	32	373
1970	21198 Paleologou KE, Schmid AW, Rospigliosi CC, Kim HY, Lamberto GR, et al. Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 JUN 13; 283 (24): 16895-16905	26	29	32	44
#	Date / Author / Journal	LCS	GCS	LCR	CR
1971	21560 Agnati LF, Baldelli E, Andreoli N, Woods AS, Vellani V, et al. On the key role played by altered protein conformation in Parkinson's disease JOURNAL OF NEURAL TRANSMISSION. 2008 SEP; 115 (9): 1285-1299	3	3	32	94
1972	21587 Rankin CA, Sun Q, Gamblin TC Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle- like structures NEUROBIOLOGY OF DISEASE. 2008 SEP; 31 (3): 368-377	2	3	32	36
1973	21907 Ramsey CP, Giasson BI The E163K DJ-1 mutant shows specific antioxidant deficiency BRAIN RESEARCH. 2008 NOV 6; 1239: 1-11	3	6	32	55
1974	22008 Martinez A, Carmona M, Portero-Otin M, Naudi A, Pamplona R, et al. Type-Dependent Oxidative Damage in Frontotemporal Lobar Degeneration: Cortical Astrocytes Are Targets of Oxidative Damage JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2008 DEC; 67 (12): 1122-1136	4	8	32	58
1975	22088 Sato S, Xu JQ, Okuyama S, Martinez LB, Walsh SM, et al. Spatial Learning Impairment, Enhanced CDK5/p35 Activity, and Downregulation of NMDA Receptor Expression in Transgenic Mice Expressing Tau-Tubulin Kinase 1 JOURNAL OF NEUROSCIENCE. 2008 DEC 31; 28 (53): 14511-14521	6	11	32	76
1976	22106 Bulic B, Pickhardt M, Schmidt B, Mandelkow EM, Waldmann H, et al. Development of Tau Aggregation Inhibitors for Alzheimer's Disease ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2009; 48 (10): 1741-1752	16	29	32	97
1977	22148 Schneider P, Hampel H, Buerger K Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum CNS NEUROSCIENCE & THERAPEUTICS. 2009; 15 (4): 358-374	2	3	32	151
1978	22200 Bakota L, Brandt R LIVE-CELL IMAGING IN THE STUDY OF NEURODEGENERATION INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 276. 2009; 276: 49-103	1	2	32	175
1979	22288 Bozoki AC, Farooq MU FRONTOTEMPORAL LOBAR DEGENERATION: INSIGHTS FROM NEUROPSYCHOLOGY AND NEUROIMAGING NEUROBIOLOGY OF DEMENTIA. 2009; 84: 185-+	0	1	32	100
1980	22392 Clarimon J, Molina-Porcel L, Gomez-Isla T, Blesa R, Guardia-Laguarta C, et al. Early-Onset Familial Lewy Body Dementia With Extensive Tauopathy: A Clinical, Genetic, and Neuropathological Study JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 JAN; 68 (1): 73-82	3	4	32	43
#	Date / Author / Journal	LCS	GCS	LCR	CR
1981	22493 Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies ACTA NEUROPATHOLOGICA. 2009 FEB; 117 (2): 137-149	44	44	32	39
1982	22915 Kjaer L, Giehm L, Heimburg T, Otzen D The Influence of Vesicle Size and Composition on alpha-Synuclein Structure and Stability BIOPHYSICAL JOURNAL. 2009 APR 8; 96 (7): 2857-2870	3	5	32	64
1983	22949 Szargel R, Rott R, Eyal A, Haskin J, Shani V, et al. Synphilin-1A Inhibits Seven in Absentia Homolog (SIAH) and Modulates alpha-Synuclein Monoubiquitylation and Inclusion Formation JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 APR 24; 284 (17): 11706-11716	3	6	32	51
1984	23048 Gandhi PN, Chen SG, Wilson-Delfosse AL Leucine-Rich Repeat Kinase 2 (LRRK2): A Key Player in the Pathogenesis of Parkinson's Disease JOURNAL OF NEUROSCIENCE RESEARCH. 2009 MAY 1; 87 (6): 1283-1295	4	14	32	135
1985	23277 Biskup S, West AB Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 625-633	3	12	32	111
1986	23298 Reiner O, Shmueli A, Sapir T Neuronal Migration and Neurodegeneration: 2 Sides of the Same Coin CEREBRAL CORTEX. 2009 JUL; 19: I42-I48	0	1	32	125
1987	23382 McClendon S, Rospigliosi CC, Eliezer D Charge neutralization and collapse of the C-terminal tail of alpha- synuclein at low pH PROTEIN SCIENCE. 2009 JUL; 18 (7): 1531-1540	4	8	32	57
1988	23387 Zatta P, Drago D, Bolognin S, Sensi SL Alzheimer's disease, metal ions and metal homeostatic therapy TRENDS IN PHARMACOLOGICAL SCIENCES. 2009 JUL; 30 (7): 346-355	3	23	32	116
1989	23519 Pasquali L, Longone P, Isidoro C, Ruggieri S, Paparelli A, et al. AUTOPHAGY, LITHIUM, AND AMYOTROPHIC LATERAL SCLEROSIS MUSCLE & NERVE. 2009 AUG; 40 (2): 173-194	6	9	32	181
1990	23586 Nonaka T, Hasegawa M A Cellular Model To Monitor Proteasome Dysfunction by alpha-Synuclein BIOCHEMISTRY. 2009 AUG 25; 48 (33): 8014-8022	3	3	32	42
#	Date / Author / Journal	LCS	GCS	LCR	CR
1991	23619 Kovacech B, Zilka N, Novak M New Age of Neuroproteomics in Alzheimer's Disease Research CELLULAR AND MOLECULAR NEUROBIOLOGY. 2009 SEP; 29 (6-7): 799-805	0	3	32	63
1992	23678 Higashi S, Moore DJ, Yamamoto R, Minegishi M, Sato K, et al. Abnormal Localization of Leucine-Rich Repeat Kinase 2 to the Endosomal- Lysosomal Compartment in Lewy Body Disease JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 SEP; 68 (9): 994-1005	3	3	32	60
1993	23692 Peruzzi PP, Lawler SE, Senior SL, Dmitrieva N, Edser PAH, et al. Physiological Transgene Regulation and Functional Complementation of a Neurological Disease Gene Deficiency in Neurons MOLECULAR THERAPY. 2009 SEP; 17 (9): 1517-1526	0	0	32	49
1994	23767 Tan CF, Yamada M, Toyoshima Y, Yokoseki A, Miki Y, et al. Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease ACTA NEUROPATHOLOGICA. 2009 OCT; 118 (4): 553-560	3	4	32	36
1995	23901 Souter S, Lee G Microtubule-Associated Protein Tau in Human Prostate Cancer Cells: Isoforms, Phosphorylation, and Interactions JOURNAL OF CELLULAR BIOCHEMISTRY. 2009 OCT 15; 108 (3): 555-564	2	2	32	50
1996	23932 Klein C, Schneider SA, Lang AE Hereditary Parkinsonism: Parkinson Disease Look-Alikes-An Algorithm for Clinicians to "PARK" Genes and Beyond MOVEMENT DISORDERS. 2009 OCT 30; 24 (14): 2042-2058	4	6	32	184
1997	23991 Butterfield DA, Lange MLB Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism JOURNAL OF NEUROCHEMISTRY. 2009 NOV; 111 (4): 915-933	2	7	32	231
1998	24048 Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, et al. The heritability and genetics of frontotemporal lobar degeneration NEUROLOGY. 2009 NOV 3; 73 (18): 1451-1456	4	5	32	39
1999	24217 Mo ZY, Zhu YZ, Zhu HL, Fan JB, Chen J, et al. Low Micromolar Zinc Accelerates the Fibrillization of Human Tau via Bridging of Cys-291 and Cys-322 JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 DEC 11; 284 (50): 34648-34657	0	4	32	69
2000	24364 Qian W, Shi JH, Yin XM, Iqbal K, Grundke-Iqbal I, et al. PP2A Regulates Tau Phosphorylation Directly and also Indirectly via Activating GSK-3 beta JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (4): 1221-1229	0	5	32	56

Date / Author / Journal

LCS

GCS

LCR

1901

11225 Kirkitadze MD, Bitan G, Teplow DB

Paradigm shifts in Alzheimer's disease and other neuro degenerative disorders: The emerging role of oligomeric assemblies

JOURNAL OF NEUROSCIENCE RESEARCH. 2002 SEP 1; 69 (5): 567-577

217

154

1902

11274 Thompson AJ, Barrow CJ

Protein conformational misfolding and amyloid formation: Characteristics of a new class of disorders that include Alzheimer's and prion diseases

CURRENT MEDICINAL CHEMISTRY. 2002 OCT; 9 (19): 1751-1762

164

1903

11299 Dong ZZ, Ferger B, Feldon J, Bueler H

Overexpression of Parkinson's disease-associated alpha-synuclein(A53T) by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP

JOURNAL OF NEUROBIOLOGY. 2002 OCT; 53 (1): 1-10

1904

11471 Li L, von Bergen M, Mandelkow EM, Mandelkow E

Structure, stability, and aggregation of paired helical filaments from tau protein and FTDP-17 mutants probed by tryptophan scanning mutagenesis

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 NOV 1; 277 (44): 41390-41400

1905

11775 Schluter OM, Fornai F, Alessandri MG, Takamori S, Geppert M, et al.

Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetra- hydropyridine-induced parkinsonism in mice

NEUROSCIENCE. 2003; 118 (4): 985-1002

1906

11889 Cho JH, Johnson GVW

Glycogen synthase kinase 3 beta phosphorylates tau at both primed and unprimed sites - Differential impact on microtubule binding

JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 JAN 3; 278 (1): 187-193

1907

11991 Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM

Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2003 FEB 18; 100 (4): 2047-2052

100

1908

12102 Yang YF, Nishimura I, Imai Y, Takahashi R, Lu BW

Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila

NEURON. 2003 MAR 27; 37 (6): 911-924

112

181

1909

12144 Watson DJ, Longhi L, Lee EB, Fulp CT, Fujimoto S, et al.

Genetically modified NT2N human neuronal cells mediate long-term gene expression as CNS grafts in vivo and improve functional cognitive outcome following experimental traumatic brain injury

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2003 APR; 62 (4): 368-380

1910

12395 Gervasi C, Thyagarajan A, Szaro BG

Increased expression of multiple neurofilament mRNAs during regeneration of vertebrate central nervous system axons

JOURNAL OF COMPARATIVE NEUROLOGY. 2003 JUN 23; 461 (2): 262-275

Date / Author / Journal

LCS

GCS

LCR

1911

12414 Beach TG, Sue L, Scott S, Layne K, Newell A, et al.

Hippocampal sclerosis dementia with tauopathy

BRAIN PATHOLOGY. 2003 JUL; 13 (3): 263-278

1912

12461 Frank RA, Galasko D, Hampel H, Hardy J, de Leon MJ, et al.

Biological markers for therapeutic trials in Alzheimer's disease - Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

NEUROBIOLOGY OF AGING. 2003 JUL-AUG; 24 (4): 521-536

120

119

165

1913

12466 Dev KK, van der Putten H, Sommer B, Rovelli G

Part I: Parkin-associated proteins and Parkinson's disease

NEUROPHARMACOLOGY. 2003 JUL; 45 (1): 1-13

102

1914

12614 Bussiere T, Giannakopoulos P, Bouras C, Perl DP, Morrison JH, et al.

Progressive degeneration of nonphosphorylated neurofilament protein- enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: Stereologic analysis of prefrontal cortex area 9

JOURNAL OF COMPARATIVE NEUROLOGY. 2003 AUG 25; 463 (3): 281-302

102

1915

12632 Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, et al.

Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice

AMERICAN JOURNAL OF PATHOLOGY. 2003 SEP; 163 (3): 1057-1067

1916

12682 Lee SS, Kim YM, Junn E, Lee G, Park KH, et al.

Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies

NEUROBIOLOGY OF AGING. 2003 SEP; 24 (5): 687-696

1917

12792 Andringa G, Du F, Chase TN, Bennett MC

Mapping of rat brain using the synuclein-1 monoclonal antibody reveals somatodendritic expression of alpha-synuclein in populations of neurons homologous to those vulnerable to Lewy body formation in human synucleopathies

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2003 OCT; 62 (10): 1060-1075

1918

13101 Petrucelli L, Dawson TM

Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system

ANNALS OF MEDICINE. 2004; 36 (4): 315-320

1919

13336 Bartzokis G

NEUROBIOLOGY OF AGING. 2004 JAN; 25 (1): 5-18

187

272

1920

13914 Pickering-Brown SM, Baker M, Nonaka T, Ikeda K, Sharma S, et al.

Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene

BRAIN. 2004 JUN; 127: 1415-1426

Date / Author / Journal

LCS

GCS

LCR

1921

13923 Imai Y, Takahashi R

How do Parkin mutations result in neurodegeneration?

CURRENT OPINION IN NEUROBIOLOGY. 2004 JUN; 14 (3): 384-389

1922

14114 Hasegawa T, Matsuzaki M, Takeda A, Kikuchi A, Akita H, et al.

Accelerated alpha-synuclein aggregation after differentiation of SH- SY5Y neuroblastoma cells

BRAIN RESEARCH. 2004 JUL 2; 1013 (1): 51-59

1923

14510 Wirths O, Multhaup G, Bayer TA

A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide - the first step of a fatal cascade

JOURNAL OF NEUROCHEMISTRY. 2004 NOV; 91 (3): 513-520

112

1924

14584 Lee JC, Langen R, Hummel PA, Gray HB, Winkler JR

alpha-synuclein structures from fluorescence energy-transfer kinetics: Implications for the role of the protein in Parkinson's disease

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004 NOV 23; 101 (47): 16466-16471

1925

14621 Hashimoto M, Rockenstein E, Mante M, Crews L, Bar-On P, et al.

An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model

GENE THERAPY. 2004 DEC; 11 (23): 1713-1723

1926

14692 Cherny D, Hoyer W, Subramaniam V, Jovin TM

Double-stranded DNA stimulates the fibrillation of alpha-synuclein in vitro and is associated with the mature fibrils: An electron microscopy study

JOURNAL OF MOLECULAR BIOLOGY. 2004 DEC 3; 344 (4): 929-938

1927

14753 Schmidt B, Braun HA, Narlawar R

Drug development and PET-diagnostics for Alzheimer's disease

CURRENT MEDICINAL CHEMISTRY. 2005; 12 (14): 1677-1695

248

1928

14840 Diaz-Corrales FJ, Asanuma M, Miyazaki I, Miyoshi K, Ogawa N

Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: Relevance to formation of inclusion bodies and neurodegeneration

NEUROSCIENCE. 2005; 133 (1): 117-135

1929

14848 Woodhouse A, West AK, Chuckowree JA, Vickers JC, Dickson TC

Does beta-amyloid plaque formation cause structural injury to neuronal processes?

NEUROTOXICITY RESEARCH. 2005; 7 (1-2): 5-15

104

1930

15000 Eliezer D, Barre P, Kobaslija M, Chan D, Li XH, et al.

Residual structure in the repeat domain of tau: Echoes of microtubule binding and paired helical filament formation

BIOCHEMISTRY. 2005 JAN 25; 44 (3): 1026-1036

Date / Author / Journal

LCS

GCS

LCR

1931

15042 Yamada M, Mizuno Y, Mochizuki H

Parkin gene therapy for alpha-synucleinopathy: A rat model of Parkinson's disease

HUMAN GENE THERAPY. 2005 FEB; 16 (2): 262-270

1932

15067 Specht CG, Tigaret CM, Rast GF, Thalhammer A, Rudhard Y, et al.

Subcellular localisation of recombinant alpha- and gamma-synuclein

MOLECULAR AND CELLULAR NEUROSCIENCE. 2005 FEB; 28 (2): 326-334

1933

15462 Yang WC, Ang LC, Strong MJ

Tau protein aggregation in the frontal and entorhinal cortices as a function of aging

DEVELOPMENTAL BRAIN RESEARCH. 2005 MAY 12; 156 (2): 127-138

1934

15529 Bertram L, Tanzi RE

The genetic epidemidogy of neurodegenerative disease

JOURNAL OF CLINICAL INVESTIGATION. 2005 JUN; 115 (6): 1449-1457

1935

15602 Shin YG, Klucken J, Patterson C, Hyman BT, McLean PJ

The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 JUN 24; 280 (25): 23727-23734

1936

15784 Fillon G, Kahle PJ

Alpha-synuclein transgenic mice: Relevance to multiple system atrophy

MOVEMENT DISORDERS. 2005 AUG; 20: S64-S66

1937

15891 Luna-Munoz J, Garcia-Sierra F, Falcon V, Menendez I, Chavez-Macias L, et al.

Regional conformational change involving phosphorylation of tau protein at the Thr(231), precedes the structural change detected by Alz-50 antibody in Alzheimer's disease

JOURNAL OF ALZHEIMERS DISEASE. 2005 SEP; 8 (1): 29-41

1938

15933 Flower TR, Chesnokova LS, Froelich CA, Dixon C, Witt SN

Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease

JOURNAL OF MOLECULAR BIOLOGY. 2005 SEP 2; 351 (5): 1081-1100

1939

15938 Sakaue F, Saito T, Sato Y, Asada A, Ishiguro K, et al.

Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 SEP 9; 280 (36): 31522-31529

1940

16083 Rodriguez-Martin T, Garcia-Blanco MA, Mansfield SG, Grover AC, Hutton M, et al.

Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: Implications for tauopathies

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2005 OCT 25; 102 (43): 15659-15664

Date / Author / Journal

LCS

GCS

LCR

1941

16168 Rampello L, Butta V, Raffaele R, Vecchio I, Battaglia G, et al.

Progressive supranuclear palsy: A systematic review

NEUROBIOLOGY OF DISEASE. 2005 NOV; 20 (2): 179-186

108

1942

16198 Springer W, Hoppe T, Schmidt E, Baumeister R

A Caenorhabditis elegans Parkin mutant with altered solubility couples alpha-synuclein aggregation to proteotoxic stress

HUMAN MOLECULAR GENETICS. 2005 NOV 15; 14 (22): 3407-3423

1943

16749 Pitkanen A, McIntosh TK

Animal. models of post-traumatic epilepsy

JOURNAL OF NEUROTRAUMA. 2006 FEB; 23 (2): 241-261

156

1944

17382 Nunomura A, Castellani RJ, Zhu XW, Moreira PI, Perry G, et al.

Involvement of oxidative stress in Alzheimer disease

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2006 JUL; 65 (7): 631-641

111

148

1945

17736 Klegeris A, Giasson BI, Zhang H, Maguire J, Pelech S, et al.

Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells

FASEB JOURNAL. 2006 OCT; 20 (12): 2000-2008

1946

17867 Gros-Louis F, Gaspar C, Rouleau GA

Genetics of familial and sporadic amyotrophic lateral sclerosis

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2006 NOV-DEC; 1762 (11-12): 956-972

186

1947

17880 Mackenzie IRA, Baker M, Pickering-Brown S, Hsiung GYR, Lindholm C, et al.

The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene

BRAIN. 2006 NOV; 129: 3081-3090

1948

17902 Codita A, Winblad B, Mohammed AH

Of mice and men: more neurobiology in dementia

CURRENT OPINION IN PSYCHIATRY. 2006 NOV; 19 (6): 555-563

130

1949

18161 Beghi E, Mennini T, Bendotti C, Bigini P, Logroscino G, et al.

The heterogeneity of amyotrophic lateral sclerosis: A possible explanation of treatment failure

CURRENT MEDICINAL CHEMISTRY. 2007; 14 (30): 3185-3200

321

1950

18207 Luo GR, Chen S, Le WD

Are heat shock proteins therapeutic target for Parkinson's disease?

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. 2007; 3 (1): 20-26

Date / Author / Journal

1951

The pathogenesis of cell death in Parkinson's disease - 2007

MOVEMENT DISORDERS. 2007; 22: S335-S342

1952

18347 Krishnan KRR

Concept of disease in geriatric psychiatry

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2007 JAN; 15 (1): 1-11

100

1953

18583 Sundar PD, Yu CE, Sieh W, Steinbart E, Garruto RM, et al.

Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia

HUMAN MOLECULAR GENETICS. 2007 FEB 1; 16 (3): 295-306

1954

18735 Fischer D, Mukrasch MD, von Bergen M, Klos-Witkowska A, Biernat J, et al.

Structural and microtubule binding properties of tau mutants of frontotemporal dementias

BIOCHEMISTRY. 2007 MAR 13; 46 (10): 2574-2582

1955

18799 Whitwell JL, Jack CR, Parisi JE, Knopman DS, Boeve BF, et al.

Rates of cerebral atrophy differ in different degenerative pathologies

BRAIN. 2007 APR; 130: 1148-1158

1956

18913 Avraham E, Rott R, Liani E, Szargel R, Engelender S

Phosphorylation of parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation

JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 APR 27; 282 (17): 12842-12850

1957

19024 Steinhilb ML, Dias-Santagata D, Mulkearns EE, Shulman JM, Biernat J, et al.

S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila

JOURNAL OF NEUROSCIENCE RESEARCH. 2007 MAY 1; 85 (6): 1271-1278

1958

19166 Thyagarajan A, Strong MJ, Szaro BG

Post-transcriptional control of neurofilaments in development and disease

EXPERIMENTAL CELL RESEARCH. 2007 JUN 10; 313 (10): 2088-2097

1959

19518 Walton JR

An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration

JOURNAL OF INORGANIC BIOCHEMISTRY. 2007 SEP; 101 (9): 1275-1284

1960

19595 Li Q, Min JK, Ahn YH, Namm JH, Kim EM, et al.

Styryl-based compounds as potential in vivo imaging agents for beta- amyloid plaques

CHEMBIOCHEM. 2007 SEP 24; 8 (14): 1679-1687

Date / Author / Journal

LCS

GCS

LCR

1961

19664 Lin YT, Cheng JT, Liang LC, Ko CY, Lo YK, et al.

The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3 beta

JOURNAL OF NEUROCHEMISTRY. 2007 OCT; 103 (2): 802-813

1962

19685 Uversky VN

Nanoimaging in protein-misfolding and -conformational diseases

NANOMEDICINE. 2007 OCT; 2 (5): 615-643

202

1963

19744 Cummings JL, Rachelle D, Clark C

Disease-modifying therapies for Alzheimer disease

NEUROLOGY. 2007 OCT 16; 69 (16): 1622-1634

156

1964

19756 Ingelsson M, Ramasamy K, Russ C, Freeman SH, Orne J, et al.

Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains

ACTA NEUROPATHOLOGICA. 2007 NOV; 114 (5): 471-479

1965

19772 Selenica ML, Jensen HS, Larsen AK, Pedersen ML, Helboe L, et al.

Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation

BRITISH JOURNAL OF PHARMACOLOGY. 2007 NOV; 152 (6): 959-979

1966

19910 Staal JA, Dickson TC, Chung RS, Vickers JC

Cyclosporin-A treatment attenuates delayed cytoskeletal alterations and secondary axotomy following mild axonal stretch injury

DEVELOPMENTAL NEUROBIOLOGY. 2007 DEC; 67 (14): 1831-1842

1967

20775 Nathalie P, Jean-Noel O

Processing of amyloid precursor protein and amyloid peptide neurotoxicity

CURRENT ALZHEIMER RESEARCH. 2008 APR; 5 (2): 92-99

146

1968

20888 Kostka M, Hogen T, Danzer KM, Levin J, Habeck M, et al.

Single particle characterization of iron-induced pore-forming alpha- synuclein oligomers

JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 APR 18; 283 (16): 10992-11003

1969

20986 Schaeffer EL, Gattaz WF

Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A(2) enzyme

PSYCHOPHARMACOLOGY. 2008 MAY; 198 (1): 1-27

373

1970

21198 Paleologou KE, Schmid AW, Rospigliosi CC, Kim HY, Lamberto GR, et al.

Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein

JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 JUN 13; 283 (24): 16895-16905

Date / Author / Journal

LCS

GCS

LCR

1971

21560 Agnati LF, Baldelli E, Andreoli N, Woods AS, Vellani V, et al.

On the key role played by altered protein conformation in Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION. 2008 SEP; 115 (9): 1285-1299

1972

21587 Rankin CA, Sun Q, Gamblin TC

Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle- like structures

NEUROBIOLOGY OF DISEASE. 2008 SEP; 31 (3): 368-377

1973

21907 Ramsey CP, Giasson BI

The E163K DJ-1 mutant shows specific antioxidant deficiency

BRAIN RESEARCH. 2008 NOV 6; 1239: 1-11

1974

22008 Martinez A, Carmona M, Portero-Otin M, Naudi A, Pamplona R, et al.

Type-Dependent Oxidative Damage in Frontotemporal Lobar Degeneration: Cortical Astrocytes Are Targets of Oxidative Damage

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2008 DEC; 67 (12): 1122-1136

1975

22088 Sato S, Xu JQ, Okuyama S, Martinez LB, Walsh SM, et al.

Spatial Learning Impairment, Enhanced CDK5/p35 Activity, and Downregulation of NMDA Receptor Expression in Transgenic Mice Expressing Tau-Tubulin Kinase 1

JOURNAL OF NEUROSCIENCE. 2008 DEC 31; 28 (53): 14511-14521

1976

22106 Bulic B, Pickhardt M, Schmidt B, Mandelkow EM, Waldmann H, et al.

Development of Tau Aggregation Inhibitors for Alzheimer's Disease

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2009; 48 (10): 1741-1752

1977

22148 Schneider P, Hampel H, Buerger K

Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum

CNS NEUROSCIENCE & THERAPEUTICS. 2009; 15 (4): 358-374

151

1978

22200 Bakota L, Brandt R

LIVE-CELL IMAGING IN THE STUDY OF NEURODEGENERATION

INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 276. 2009; 276: 49-103

175

1979

22288 Bozoki AC, Farooq MU

FRONTOTEMPORAL LOBAR DEGENERATION: INSIGHTS FROM NEUROPSYCHOLOGY AND NEUROIMAGING

NEUROBIOLOGY OF DEMENTIA. 2009; 84: 185-+

100

1980

22392 Clarimon J, Molina-Porcel L, Gomez-Isla T, Blesa R, Guardia-Laguarta C, et al.

Early-Onset Familial Lewy Body Dementia With Extensive Tauopathy: A Clinical, Genetic, and Neuropathological Study

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 JAN; 68 (1): 73-82

Date / Author / Journal

LCS

GCS

LCR

1981

22493 Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, et al.

Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies

ACTA NEUROPATHOLOGICA. 2009 FEB; 117 (2): 137-149

1982

22915 Kjaer L, Giehm L, Heimburg T, Otzen D

The Influence of Vesicle Size and Composition on alpha-Synuclein Structure and Stability

BIOPHYSICAL JOURNAL. 2009 APR 8; 96 (7): 2857-2870

1983

22949 Szargel R, Rott R, Eyal A, Haskin J, Shani V, et al.

Synphilin-1A Inhibits Seven in Absentia Homolog (SIAH) and Modulates alpha-Synuclein Monoubiquitylation and Inclusion Formation

JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 APR 24; 284 (17): 11706-11716

1984

23048 Gandhi PN, Chen SG, Wilson-Delfosse AL

Leucine-Rich Repeat Kinase 2 (LRRK2): A Key Player in the Pathogenesis of Parkinson's Disease

JOURNAL OF NEUROSCIENCE RESEARCH. 2009 MAY 1; 87 (6): 1283-1295

135

1985

23277 Biskup S, West AB

Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 625-633

111

1986

23298 Reiner O, Shmueli A, Sapir T

Neuronal Migration and Neurodegeneration: 2 Sides of the Same Coin

CEREBRAL CORTEX. 2009 JUL; 19: I42-I48

125

1987

23382 McClendon S, Rospigliosi CC, Eliezer D

Charge neutralization and collapse of the C-terminal tail of alpha- synuclein at low pH

PROTEIN SCIENCE. 2009 JUL; 18 (7): 1531-1540

1988

23387 Zatta P, Drago D, Bolognin S, Sensi SL

Alzheimer's disease, metal ions and metal homeostatic therapy

TRENDS IN PHARMACOLOGICAL SCIENCES. 2009 JUL; 30 (7): 346-355

116

1989

23519 Pasquali L, Longone P, Isidoro C, Ruggieri S, Paparelli A, et al.

AUTOPHAGY, LITHIUM, AND AMYOTROPHIC LATERAL SCLEROSIS

MUSCLE & NERVE. 2009 AUG; 40 (2): 173-194

181

1990

23586 Nonaka T, Hasegawa M

A Cellular Model To Monitor Proteasome Dysfunction by alpha-Synuclein

BIOCHEMISTRY. 2009 AUG 25; 48 (33): 8014-8022

Date / Author / Journal

LCS

GCS

LCR

1991

23619 Kovacech B, Zilka N, Novak M

New Age of Neuroproteomics in Alzheimer's Disease Research

CELLULAR AND MOLECULAR NEUROBIOLOGY. 2009 SEP; 29 (6-7): 799-805

1992

23678 Higashi S, Moore DJ, Yamamoto R, Minegishi M, Sato K, et al.

Abnormal Localization of Leucine-Rich Repeat Kinase 2 to the Endosomal- Lysosomal Compartment in Lewy Body Disease

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 SEP; 68 (9): 994-1005

1993

23692 Peruzzi PP, Lawler SE, Senior SL, Dmitrieva N, Edser PAH, et al.

Physiological Transgene Regulation and Functional Complementation of a Neurological Disease Gene Deficiency in Neurons

MOLECULAR THERAPY. 2009 SEP; 17 (9): 1517-1526

1994

23767 Tan CF, Yamada M, Toyoshima Y, Yokoseki A, Miki Y, et al.

Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease

ACTA NEUROPATHOLOGICA. 2009 OCT; 118 (4): 553-560

1995

23901 Souter S, Lee G

Microtubule-Associated Protein Tau in Human Prostate Cancer Cells: Isoforms, Phosphorylation, and Interactions

JOURNAL OF CELLULAR BIOCHEMISTRY. 2009 OCT 15; 108 (3): 555-564

1996

23932 Klein C, Schneider SA, Lang AE

Hereditary Parkinsonism: Parkinson Disease Look-Alikes-An Algorithm for Clinicians to "PARK" Genes and Beyond

MOVEMENT DISORDERS. 2009 OCT 30; 24 (14): 2042-2058

184

1997

23991 Butterfield DA, Lange MLB

Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism

JOURNAL OF NEUROCHEMISTRY. 2009 NOV; 111 (4): 915-933

231

1998

24048 Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, et al.

The heritability and genetics of frontotemporal lobar degeneration

NEUROLOGY. 2009 NOV 3; 73 (18): 1451-1456

1999

24217 Mo ZY, Zhu YZ, Zhu HL, Fan JB, Chen J, et al.

Low Micromolar Zinc Accelerates the Fibrillization of Human Tau via Bridging of Cys-291 and Cys-322

JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 DEC 11; 284 (50): 34648-34657

2000

24364 Qian W, Shi JH, Yin XM, Iqbal K, Grundke-Iqbal I, et al.

PP2A Regulates Tau Phosphorylation Directly and also Indirectly via Activating GSK-3 beta

JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (4): 1221-1229

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records